Description
Inspire Medical Systems: Is The New Inspire V System A Game Changer?
Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant
revenue growth and improvements in profitability. The company’s revenue for the third quarter was
$203.2 million, up 33% compared to the same period in 2023. This growth was predominantly
driven by the increased adoption of Inspire therapy, reflected in the expansion into 66 new
implanting centers and growth in 13 new U.S. sales territories. Inspire now operates with 1,371
active U.S. centers and 323 sales territories, witnessing consistent utilization year-over-year.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
